Dr. Abida on Genetic Testing for Prostate Cancer

Wassim Abida, MD, PhD
Published: Tuesday, Mar 21, 2017



Wassim Abida, MD, PhD, medical oncologist, Developmental Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses genetic testing for patients with prostate cancer.

The process of genetic testing for patients is not complicated, but the difficulty is figuring out who should be tested and what specific genes should be investigated, explains Abida.

Genetic testing is very important because it can affect decisions regarding treatment and screening for patients with prostate cancer and their families, states Abida.
 


Wassim Abida, MD, PhD, medical oncologist, Developmental Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses genetic testing for patients with prostate cancer.

The process of genetic testing for patients is not complicated, but the difficulty is figuring out who should be tested and what specific genes should be investigated, explains Abida.

Genetic testing is very important because it can affect decisions regarding treatment and screening for patients with prostate cancer and their families, states Abida.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x